DK1007006T3 - Formulering af cefadroxilmonohydrattablet - Google Patents
Formulering af cefadroxilmonohydrattabletInfo
- Publication number
- DK1007006T3 DK1007006T3 DK98911832T DK98911832T DK1007006T3 DK 1007006 T3 DK1007006 T3 DK 1007006T3 DK 98911832 T DK98911832 T DK 98911832T DK 98911832 T DK98911832 T DK 98911832T DK 1007006 T3 DK1007006 T3 DK 1007006T3
- Authority
- DK
- Denmark
- Prior art keywords
- formulation
- cefadroxil monohydrate
- tablet
- monohydrate tablet
- cefadroxil
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4414097P | 1997-04-17 | 1997-04-17 | |
PCT/US1998/005412 WO1998046213A1 (en) | 1997-04-17 | 1998-03-19 | Cefadroxil monohydrate tablet formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1007006T3 true DK1007006T3 (da) | 2003-09-29 |
Family
ID=21930720
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98911832T DK1007006T3 (da) | 1997-04-17 | 1998-03-19 | Formulering af cefadroxilmonohydrattablet |
Country Status (11)
Country | Link |
---|---|
US (1) | US6080427A (da) |
EP (1) | EP1007006B1 (da) |
JP (1) | JP2002514212A (da) |
AT (1) | ATE243504T1 (da) |
AU (1) | AU729437B2 (da) |
CA (1) | CA2286079A1 (da) |
DE (1) | DE69815856T2 (da) |
DK (1) | DK1007006T3 (da) |
ES (1) | ES2201465T3 (da) |
PT (1) | PT1007006E (da) |
WO (1) | WO1998046213A1 (da) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2814679B1 (fr) * | 2000-09-29 | 2003-04-11 | Cll Pharma | Compositions pharmaceutiques dispersibles a base de cephalosporines, leur procede de preparation et leur utilisation |
JP2004531537A (ja) * | 2001-05-01 | 2004-10-14 | ファイザー・プロダクツ・インク | 一様な薬剤分布と効力を有する低用量製薬組成物の製造方法 |
EP1293251A1 (en) * | 2001-09-14 | 2003-03-19 | Holland Sweetener Company V.o.F. | Process for the production of alpha-L-aspartyl-l-phenylalanine methyl ester powder |
GB0123400D0 (en) * | 2001-09-28 | 2001-11-21 | Novartis Ag | Organic compounds |
WO2003086361A1 (en) * | 2002-04-18 | 2003-10-23 | Dr. Reddy's Laboratories Ltd. | Rapidly dispersing solid oral compositions |
AU2003235395A1 (en) * | 2002-05-22 | 2003-12-02 | Shionogi And Co., Ltd. | Pharmaceutical preparation improved in dissolving property of drug slightly soluble in water |
TW200404550A (en) * | 2002-07-08 | 2004-04-01 | Sankyo Co | Cepharospolin formulation for oral use |
JP4526247B2 (ja) * | 2002-07-08 | 2010-08-18 | 第一三共株式会社 | 経口用セファロスポリン製剤 |
WO2004016250A1 (en) * | 2002-08-19 | 2004-02-26 | Orchid Health Care | Sustained release pharmaceutical composition of a cephalosporin antibiotic |
ATE415150T1 (de) * | 2002-08-16 | 2008-12-15 | Orchid Chemicals & Pharm Ltd | Pharmazeutische zusammensetzung mit verzögerte freisetzung enthaltend einen cephalosporin- antibiotikum |
CN1311830C (zh) * | 2004-02-27 | 2007-04-25 | 石药集团中奇制药技术(石家庄)有限公司 | 头孢羟氨苄口腔崩解片及其制备方法 |
MXPA06012944A (es) * | 2004-05-10 | 2007-02-12 | Lupin Ltd | Nueva formulaci??n farmaceutica de cefixima con mejor biodisponibilidad. |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
WO2007074472A2 (en) * | 2005-12-27 | 2007-07-05 | Jubilant Organosys Limited | Mouth dissolving pharmaceutical composition and process for preparing the same using a high amount of silicon dioxide |
WO2008104996A2 (en) * | 2007-02-28 | 2008-09-04 | Jubilant Organosys Limited | Water dispersible pharmaceutical formulation and process for preparing the same |
US20100285164A1 (en) | 2009-05-11 | 2010-11-11 | Jrs Pharma | Orally Disintegrating Excipient |
US20110097401A1 (en) | 2009-06-12 | 2011-04-28 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
CN104800177B (zh) * | 2015-05-12 | 2018-01-16 | 湖南科伦制药有限公司 | 一种头孢羟氨苄片及其制备方法 |
CN110267683A (zh) * | 2017-02-03 | 2019-09-20 | 株式会社东洋新药 | 固体制剂 |
CN111388432A (zh) * | 2020-03-19 | 2020-07-10 | 潍坊富邦药业有限公司 | 一种宠物用头孢羟氨苄片及其制备方法 |
CN113908134B (zh) * | 2021-12-03 | 2023-10-27 | 陕西恒诚制药有限公司 | 一种头孢羟氨苄分散包衣片的制备方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3584114A (en) * | 1968-05-22 | 1971-06-08 | Hoffmann La Roche | Free-flowing powders |
US3725556A (en) * | 1970-11-12 | 1973-04-03 | D Hanssen | Method of manufacturing rapidly disintegrating pharmaceutical tablets |
US4072535A (en) * | 1970-12-28 | 1978-02-07 | A. E. Staley Manufacturing Company | Precompacted-starch binder-disintegrant-filler material for direct compression tablets and dry dosage capsules |
US3873694A (en) * | 1973-09-27 | 1975-03-25 | Cpc International Inc | Direct compression tabletting composition and pharmaceutical tablets produced therefrom |
GB1532682A (en) * | 1976-04-27 | 1978-11-22 | Bristol Myers Co | Process for the preparation of cephadroxil |
FI75578C (fi) * | 1979-07-25 | 1988-07-11 | Ciba Geigy Ag | Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider. |
US4439453A (en) * | 1980-12-22 | 1984-03-27 | Monsanto Company | Directly compressible acetaminophen granulation |
US5366738A (en) * | 1982-07-29 | 1994-11-22 | Merck & Co., Inc. | Controlled release drug dispersion delivery device |
US4851228A (en) * | 1984-06-20 | 1989-07-25 | Merck & Co., Inc. | Multiparticulate controlled porosity osmotic |
EP0181966A1 (en) * | 1984-11-13 | 1986-05-28 | Gist-Brocades N.V. | Compression-coated dispersible tablets |
US4968508A (en) * | 1987-02-27 | 1990-11-06 | Eli Lilly And Company | Sustained release matrix |
US4910023A (en) * | 1988-06-09 | 1990-03-20 | Warner-Lambert Company | Drug in combination with flavor masking agent and method for making same |
US5047246A (en) * | 1988-09-09 | 1991-09-10 | Bristol-Myers Company | Direct compression cyclophosphamide tablet |
DK469989D0 (da) * | 1989-09-22 | 1989-09-22 | Bukh Meditec | Farmaceutisk praeparat |
US5284662A (en) * | 1990-10-01 | 1994-02-08 | Ciba-Geigy Corp. | Oral osmotic system for slightly soluble active agents |
US5256440A (en) * | 1992-06-22 | 1993-10-26 | Merck & Co., Inc. | Process for producing a tablet core aperture |
PL186386B1 (pl) * | 1995-02-08 | 2004-01-30 | Yamanouchi Europ Bv | Sposób wytwarzania granulatu zawierającego aktywny przy podawaniu drogą doustną antybiotyk beta-laktamowy oraz sposób wytwarzania szybko rozpadającejsię postaci dawkowania zawierającej aktywny przy podawaniu drogą doustną antybiotyk beta-laktamowy |
-
1998
- 1998-03-17 US US09/042,888 patent/US6080427A/en not_active Expired - Lifetime
- 1998-03-19 WO PCT/US1998/005412 patent/WO1998046213A1/en active IP Right Grant
- 1998-03-19 AT AT98911832T patent/ATE243504T1/de active
- 1998-03-19 PT PT98911832T patent/PT1007006E/pt unknown
- 1998-03-19 JP JP54390698A patent/JP2002514212A/ja not_active Ceased
- 1998-03-19 AU AU65697/98A patent/AU729437B2/en not_active Ceased
- 1998-03-19 CA CA002286079A patent/CA2286079A1/en not_active Abandoned
- 1998-03-19 ES ES98911832T patent/ES2201465T3/es not_active Expired - Lifetime
- 1998-03-19 DK DK98911832T patent/DK1007006T3/da active
- 1998-03-19 DE DE69815856T patent/DE69815856T2/de not_active Expired - Lifetime
- 1998-03-19 EP EP98911832A patent/EP1007006B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO1998046213A1 (en) | 1998-10-22 |
US6080427A (en) | 2000-06-27 |
PT1007006E (pt) | 2003-10-31 |
AU6569798A (en) | 1998-11-11 |
EP1007006A4 (en) | 2001-08-16 |
ATE243504T1 (de) | 2003-07-15 |
JP2002514212A (ja) | 2002-05-14 |
EP1007006B1 (en) | 2003-06-25 |
AU729437B2 (en) | 2001-02-01 |
EP1007006A1 (en) | 2000-06-14 |
DE69815856D1 (de) | 2003-07-31 |
ES2201465T3 (es) | 2004-03-16 |
DE69815856T2 (de) | 2004-05-06 |
CA2286079A1 (en) | 1998-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1007006T3 (da) | Formulering af cefadroxilmonohydrattablet | |
WO2000041681A3 (de) | ARZNEIFORMULIERUNGEN ENTHALTEND EIN OPIOID UND EINEN α-AGONISTEN | |
HK1076605A1 (en) | Formulations | |
IT1276689B1 (it) | Forma farmaceutica solida ad uso orale | |
HUP0302131A2 (hu) | Gyógyászati tramadolsók, ezeket tartalmazó gyógyszerkészítmények | |
BR9912979B1 (pt) | composição farmacêutica administrável oralmente, tablete de mascar, cápsula e uso de chitosan. | |
BG66093B1 (bg) | Състави с контролирано освобождаване, съдържащи нимесулид | |
FR11C0017I2 (fr) | Utilisation de spinosad ou d'une formulation comprennant spinosad | |
DE59802670D1 (de) | Osmotisches arzneimittelfreisetzungssystem | |
GB9808796D0 (en) | Antithrombotic agents | |
WO2000078294A3 (de) | Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac | |
ATE287264T1 (de) | Oral anzuwendende buprenorphinhaltige arzneimittel | |
BR9807992A (pt) | Comprimidos para engolir os quais compreendem paracetamol | |
ATE252377T1 (de) | Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff | |
WO2005007137A3 (de) | Ambroxolhaltige tabletten | |
EA199900102A1 (ru) | Таблетка малеата тримебутина, покрытая оболочкой | |
CA2489140A1 (en) | Dosage form containing pantoprazole as active ingredient | |
MXPA05008843A (es) | Sistema terapeutico que comprende amoxicilina y acido clavulanico. | |
TW200503785A (en) | Dosage form containing (S)-pantoprazole as active ingredient | |
HUP0001104A2 (hu) | Ibuprofent és domperidont tartalmazó készítmények migrén kezelésére | |
DK1292303T3 (da) | Stabil farmaceutisk formulering omfattende torsemidmodifikation II | |
GEP20043377B (en) | Pharmaceutical Complex | |
PT1202956E (pt) | Derivados terapeuticos e/ou nuricionalmente melhorados de ingredientes activos e composicoes de administracao oral contendo o mesmo | |
EP1273301A3 (en) | Pharmaceutical preparations based on active ingredients susceptible to illict administration | |
MY141008A (en) | Oral formulations of deoxypeganine and their uses |